ACM
LRMR icon

Aquatic Capital Management’s Larimar Therapeutics LRMR Stock Holding History

Aquatic Capital Management’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-18,160
Closed -$70.3K – 1474
2024
Q4 		$70.3K Buy
+18,160
New +$120K ﹤0.01% 1122

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Aquatic Capital Management's LRMR Position: Q1 2025 in Review

Aquatic Capital Management sold out of Larimar Therapeutics (LRMR) in Q1 2025, closing a stake of 18,160 shares — an estimated $70.3K sold.

Aquatic Capital Management first reported a position in LRMR in Q4 2024 and held it in 1 quarter. The position peaked at $70.3K in Q4 2024. 103 funds tracked by Wall St. Rank hold LRMR as of Q1 2025.

  • Aquatic Capital Management reported no remaining Larimar Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Aquatic Capital Management sold 18,160 Larimar Therapeutics shares in Q1 2025, an estimated $70.3K.
  • Aquatic Capital Management first reported a position in Larimar Therapeutics in Q4 2024 and held it in 1 quarter.
  • Aquatic Capital Management's Larimar Therapeutics position peaked at $70.3K in Q4 2024.
  • 103 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2025.

Based on Aquatic Capital Management's 13F filing for Q1 2025, filed 15 May 2025.